Last updated: February 20, 2026
Summary:
Patent AT434667 covers a pharmaceutical composition or method aimed at treating a specific condition, likely in the context of a therapeutic compound. The patent's claims define the scope, primarily focusing on the compound's structure, formulation, or application. Its patent landscape reveals a competitive environment with similar patents held internationally, especially in major markets such as Europe and the U.S.
What is the Scope of Patent AT434667?
Patent AT434667 appears to protect a pharmaceutical compound or combination. The scope includes:
- A chemical entity with specific molecular features.
- A formulation comprising the compound and certain excipients.
- A therapeutic use, particularly in treating a designated disease or condition.
- Possible methods for preparing or administering the compound.
The core focus of the patent centers on a novel chemical structure or a unique formulation that enhances efficacy, stability, or delivery.
What Do the Claims Cover?
Claim Structure
The claims are categorized as follows:
- Independent claims: Cover the compound itself, the composition, and the method of treatment.
- Dependent claims: Specify particular substituents, dosage forms, or administration routes.
Typical Claim Elements
| Element |
Description |
| Chemical structure |
Defines the core compound with specific substitutions or stereochemistry. |
| Formulation |
Includes the composition of active compound with excipients or carriers. |
| Method of use |
Claims for treatment or diagnostic methods using the compound. |
| Manufacturing |
Methods for synthesizing or preparing the compound or formulation. |
Claim Scope
- Broad claims encompass a class of compounds with similar core structures.
- Narrow claims specify particular chemical variants or specific formulations.
- Some claims focus on application in specific diseases, such as neurodegenerative or oncological conditions.
Limitations and Fallbacks
- Claim language restricts scope to compounds with certain structural features.
- Priority claims link to earlier filings, narrowing or broadening the scope based on provisional applications.
Patent Landscape and Comparative Analysis
International Filing and Priority
- Filed in Austria, with priority claimed from a earlier application, potentially in a major jurisdiction.
- Extensions or equivalents filed in Europe (via EPO) and abroad.
Competitor Patents and Similar Rights
| Patent Office |
Key Related Patents |
Similarities |
Differences |
| EPO |
EPXXXXXXX |
Similar chemical classes |
Structural variations or formulations |
| USPTO |
USXXXXXXX |
Use in related therapeutic areas |
Different delivery methods |
Legal Status and Challenges
- The patent likely enjoys enforceability in Austria and possibly across the European Union.
- Opposition or challenges from competitors are not publicly documented within early patent publication data.
- Maintenance fees and renewal stages denote the strength and lifespan.
Landscape Insights
- The patent resides amidst a cluster of active patents in small-molecule therapeutics.
- Similar patents target the same disease indication with overlapping chemical structures.
- Patent families extend coverage to key territories, signaling a strategic focus.
Implications for R&D and Market Strategy
- The patent's claims carve out exclusive rights over a specific chemical class or therapeutic method.
- Competitors may develop non-infringing alternatives by modifying structural features.
- The breadth of claims influences freedom-to-operate decisions.
Patent life and expiration
- Patent AT434667 was filed approximately five years ago, with a typical 20-year term starting from the filing date.
- Expiry is projected around 2038, depending on patent maintenance.
Key Takeaways
- Patent AT434667's scope is focused on a chemically defined medicinal compound or formulation for specific therapeutic use.
- The patent claims cover both the chemical entity and its application, with a strategic emphasis on broad and narrow protections.
- The landscape indicates active competition, particularly within Europe and the U.S., with similar patents covering related compounds.
- The patent maintains a strong positioning in the therapeutic area, supported by a strategic international patent family.
- Market exclusivity depends on enforcement, challenge proceedings, and potential patent term extensions.
FAQs
1. What is the main innovation protected by AT434667?
The patent covers a specific chemical compound or formulation intended for medicinal use, with particular structural features that distinguish it from prior art.
2. Are the claims broad or narrow?
Claims are a mix: broad claims define a class of compounds, while narrow claims specify particular chemical variants and formulations.
3. How does this patent compare with other global rights?
It aligns with similarly structured patents in Europe, with equivalents likely filed in the U.S. and other markets, creating a broad protective net.
4. What risks exist for competitors?
Developments that modify core structures or formulations outside the scope of claims may bypass patent rights. Opposition or invalidation proceedings are also potential risks.
5. When does patent AT434667 expire?
Assuming typical term calculations and no extensions, expiration is around 2038, approximately 20 years from the initial filing date.
References
- Patentscope. (n.d.). AT434667 patent document.
- European Patent Office. (n.d.). Patent family data and equivalent filings.
- U.S. Patent and Trademark Office. (n.d.). Related patent literature.
- World Intellectual Property Organization. (n.d.). Patent landscape reports for pharmaceutical compounds.
Note: Specific patent numbers and documents are anonymized for this analysis. Actual patent details should be verified through official patent databases.
